MedTrace Logo

Microsatellite Instability in Colorectal Cancers

NCT05162248 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 231

Last updated 2021-12-17

No results posted yet for this study

Summary

In this study, we aimed to identify the different histopathological features of tumors with microsatellite instability (MSI) compared to microsatellite stable (MSS) in patients who underwent surgery for colorectal cancer. We also planned to determine how MSI affects prognostic parameters.

Conditions

  • Colorectal Cancer
  • Colorectal Carcinoma
  • Microsatellite Instability High
  • Microsatellite Instability Low
  • Microsatellite Instability-High

Interventions

DIAGNOSTIC_TEST

Microsatellite instability analysis

Molecular analysis for Microsatellite Instability (MSI) status was performed using immunohistochemistry (IHC). IHC now recognized as an approved method to highly precision predict MSI in colorectal cancer.

Sponsors & Collaborators

  • Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

    lead OTHER

Principal Investigators

  • Taygun Gülşen, MD · Sultan 2. Abdulhamid Training and Research Hospital

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-07-15
Completion
2021-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05162248 on ClinicalTrials.gov